Welcome to our dedicated page for AKTIS ONCOLOGY news (Ticker: AKTS), a resource for investors and traders seeking the latest updates and insights on AKTIS ONCOLOGY stock.
Aktis Oncology, Inc. reports clinical-stage oncology developments centered on targeted radiopharmaceuticals for solid tumors. The company’s miniprotein radioconjugate platform supports AKY-1189, a Nectin-4 program with potential across urothelial, breast, non-small cell lung, colorectal, cervical, and head and neck cancers, and AKY-2519, a B7-H3 program for prostate, lung, colorectal, and other solid tumors.
Recurring updates include FDA actions such as IND clearances and Fast Track designation, clinical-trial initiations, imaging and dosimetry data presentations, business and financial results, investor-conference participation, and board and committee changes. News also covers Aktis’ collaboration with Eli Lilly and Company to develop radioconjugates outside its proprietary pipeline.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced a design win from a second WiFi 6 customer for its 5.2/5.6 GHz RF coexistence filter solutions. The new tri-band gateway/router leverages multi-user multiple-in-multiple-out (MU-MIMO) technology, requiring multiple filters from Akoustis. Production is expected to start in the first half of 2021. This follows an earlier design win for another customer and reflects a growing sales funnel in the WiFi filter market. CEO Jeff Shealy anticipates additional design wins that could lead to sustainable revenue growth.
Akoustis Technologies (NASDAQ: AKTS) announced its participation in the Oppenheimer 5G Summit on December 15, 2020. Senior management will attend virtually due to COVID-19 safety measures. The company is experiencing increased demand for its patented XBAW® RF filters as it progresses into production across various markets, including 5G and high-band WiFi, in 2020. Their product catalog expanded to 15 filters targeting multiple applications. Akoustis is committed to advancing RF filter technology in a growing multi-billion-dollar market.
Akoustis Technologies (NASDAQ: AKTS) announced a redemption notice for its $10 million, 6.5% Convertible Senior Notes, due February 1, 2021. The redemption will cover the principal amount plus accrued interest, amounting to $10.833 per $1,000 of Notes, and a make-whole payment of $184.167. Holders can opt to convert Notes at a rate of 196.08 shares per $1,000 principal amount until January 29, 2021. CEO Jeff Shealy emphasized that eliminating this debt will reduce cash interest expenses by $650,000 annually, enhancing financial flexibility.
Akoustis Technologies (NASDAQ: AKTS) announced its participation in the Craig-Hallum Alpha Select Conference on November 17, 2020. The event will take place virtually due to ongoing Covid-19 concerns. Akoustis is witnessing increased interest in its high-frequency, high-performance XBAW filters, which are now in production across various markets, including 5G infrastructure and high-band WiFi. The company has expanded its product catalog by adding 15 filters, showcasing a commitment to innovation in RF filter solutions.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced its participation in the Roth Technology Virtual Event on November 11, 2020. The company, a leader in bulk acoustic wave (BAW) RF filters, is showcasing its advanced XBAW™ technology that supports high-frequency applications, including 5G infrastructure and high-band WiFi. In 2020, Akoustis added 15 new filters to its catalog to meet growing market demands. Investors interested in connecting with Akoustis management can do so through Roth representatives or by contacting their investor relations.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announces an order for the development of a XBAW™ coexistence filter targeting 5G mobile devices. This project, expected to ramp up in the second half of 2021, comes from a leading RF front-end module maker. The order marks the second engagement from a customer for XBAW™ filters for 5G applications, emphasizing the growing demand for Akoustis' technology. The company is also undergoing a 500% capacity expansion at its Canandaigua, NY facility to meet increasing production needs.
Akoustis Technologies (NASDAQ: AKTS) hosted an investor call on Nov. 2, 2020, to discuss their business update and outlook. The company reported Q1 revenue of $636,000, marking a 74% increase from the previous quarter and 118% from core filter products. However, they incurred a GAAP operating loss of $10.3 million. Key developments include entering production in WiFi 6 and 5G networks, securing several design wins, and expanding their product catalog with 15 new filters. Despite challenges from COVID-19, the company aims for continued growth in top-line revenue.
Akoustis Technologies (AKTS) has received an order for its 3.6 GHz XBAW™ filter solution aimed at enhancing last-mile connectivity for network operators. Following the recent CBRS spectrum auctions, the company is poised for growth as it ramps production in 2021. The XBAW filters are to be used in testing fixed wireless equipment and support the rollout of 5G infrastructure. Akoustis anticipates further customer orders in this burgeoning market, which holds significant potential due to the rising demand among various communication service providers.
Akoustis Technologies (NASDAQ: AKTS) has secured a multi-year contract from DARPA under the Direct-to-Phase-2 program to develop a Piezo MEMS process design kit for its proprietary XBAW™ process. This initiative aims to enhance the design and fabrication of BAW structures, potentially leading to new applications in RF filters for both commercial and defense markets. Upon completion, DARPA may fund a Phase 3 program to support customer engagements using the new PDK. With growing interest in its XBAW™ technology, Akoustis is expanding its product catalog to include various RF filters, targeting the rapidly evolving 5G and WiFi markets.
Akoustis, Inc. (NASDAQ: AKTS) will hold an investor update call on November 2, 2020, at 8:00 a.m. ET to discuss its business outlook and recent developments. The call is open for questions and will be accessible via telephone or webcast. Akoustis, a leader in bulk acoustic wave (BAW) RF filters, has entered production in multiple sectors, including 5G and high-band WiFi, adding 15 new filters to its catalog this year. The company focuses on innovation in RF technology targeting high-performance applications.